GLP3-RT 40mg

This compound is a novel synthetic peptide engineered to act as a triagonist at the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors. Its multi-receptor pharmacology has positioned it as a compound of significant research interest in the study of energy homeostasis, hepatic function, and integrated metabolic signaling. This 40mg lyophilized preparation is the highest-quantity option available, designed for extended or large-scale research protocols. Intended strictly for in vitro research and laboratory investigation. Not for human consumption.